185 related articles for article (PubMed ID: 8175651)
1. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
Tessler S; Rockwell P; Hicklin D; Cohen T; Levi BZ; Witte L; Lemischka IR; Neufeld G
J Biol Chem; 1994 Apr; 269(17):12456-61. PubMed ID: 8175651
[TBL] [Abstract][Full Text] [Related]
2. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
[TBL] [Abstract][Full Text] [Related]
6. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.
Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G
Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent.
Chiang MK; Flanagan JG
Growth Factors; 1995; 12(1):1-10. PubMed ID: 8527158
[TBL] [Abstract][Full Text] [Related]
8. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
[TBL] [Abstract][Full Text] [Related]
9. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
[TBL] [Abstract][Full Text] [Related]
10. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.
Soker S; Gollamudi-Payne S; Fidder H; Charmahelli H; Klagsbrun M
J Biol Chem; 1997 Dec; 272(50):31582-8. PubMed ID: 9395496
[TBL] [Abstract][Full Text] [Related]
12. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.
Roeckl W; Hecht D; Sztajer H; Waltenberger J; Yayon A; Weich HA
Exp Cell Res; 1998 May; 241(1):161-70. PubMed ID: 9633524
[TBL] [Abstract][Full Text] [Related]
13. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park JE; Chen HH; Winer J; Houck KA; Ferrara N
J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
[TBL] [Abstract][Full Text] [Related]
14. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L
Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750
[TBL] [Abstract][Full Text] [Related]
16. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and its receptors.
Neufeld G; Tessler S; Gitay-Goren H; Cohen T; Levi BZ
Prog Growth Factor Res; 1994; 5(1):89-97. PubMed ID: 7515293
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
Soker S; Takashima S; Miao HQ; Neufeld G; Klagsbrun M
Cell; 1998 Mar; 92(6):735-45. PubMed ID: 9529250
[TBL] [Abstract][Full Text] [Related]
19. Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165.
Gengrinovitch S; Berman B; David G; Witte L; Neufeld G; Ron D
J Biol Chem; 1999 Apr; 274(16):10816-22. PubMed ID: 10196157
[TBL] [Abstract][Full Text] [Related]
20. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells.
Yang X; Cepko CL
J Neurosci; 1996 Oct; 16(19):6089-99. PubMed ID: 8815891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
